Stock Track | Eli Lilly Plunges 5% as Lawsuits and RFK Jr. Nomination Spook Investors-To The Moon - Tiger Brokers Online Investing Community - To The Moon

2
Comment
Favorite

Stock Track | Eli Lilly Plunges 5% as Lawsuits and RFK Jr. Nomination Spook Investors

Stock Track11-16

Shares of pharmaceutical giant Eli Lilly & Co. (LLY) plummeted 5.03% on Friday, amid a broader market selloff and concerns over the company's legal battles with federal health agencies and the potential impact of Robert F. Kennedy Jr.'s nomination as the head of the Department of Health and Human Services (HHS).

The Indianapolis-based drugmaker's stock took a hit after the company filed a lawsuit against the U.S. Health Resources and Services Administration (HRSA) over the agency's rejection of Eli Lilly's proposed changes to the way it provides drug discounts to hospitals under the 340B program. The company argued that its new payment model would increase transparency and efficiency, but HRSA deemed it inconsistent with the law.

Adding to investor concerns, President-elect Donald Trump nominated Robert F. Kennedy Jr., a vocal critic of the pharmaceutical industry and vaccine skeptic, to lead the HHS. Kennedy has expressed opposition to the new class of GLP-1 drugs for weight loss and diabetes management, which are key products for Eli Lilly and its Danish rival Novo Nordisk. Shares of both companies tumbled on the news, as investors feared Kennedy's potential policies could hamper the growth of these lucrative drug franchises.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

2

Report

Comment

empty

No comments yet

Most Discussed

7x24

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1186989778?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-16 04:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186989778","market":"us","top_or_hot":-1,"title":"Stock Track | Eli Lilly Plunges 5% as Lawsuits and RFK Jr. Nomination Spook Investors","media":"Stock Track","content":"<p>Shares of pharmaceutical giant Eli Lilly & Co. (LLY) plummeted 5.03% on Friday, amid a broader market selloff and concerns over the company's legal battles with federal health agencies and the potential impact of Robert F. Kennedy Jr.'s nomination as the head of the Department of Health and Human Services (HHS).</p>\n\n<p>The Indianapolis-based drugmaker's stock took a hit after the company filed a lawsuit against the U.S. Health Resources and Services Administration (HRSA) over the agency's rejection of Eli Lilly's proposed changes to the way it provides drug discounts to hospitals under the 340B program. The company argued that its new payment model would increase transparency and efficiency, but HRSA deemed it inconsistent with the law.</p>\n\n<p>Adding to investor concerns, President-elect Donald Trump nominated Robert F. Kennedy Jr., a vocal critic of the pharmaceutical industry and vaccine skeptic, to lead the HHS. Kennedy has expressed opposition to the new class of GLP-1 drugs for weight loss and diabetes management, which are key products for Eli Lilly and its Danish rival Novo Nordisk. Shares of both companies tumbled on the news, as investors feared Kennedy's potential policies could hamper the growth of these lucrative drug franchises.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Eli Lilly Plunges 5% as Lawsuits and RFK Jr. Nomination Spook Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Eli Lilly Plunges 5% as Lawsuits and RFK Jr. Nomination Spook Investors\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-16 04:52 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of pharmaceutical giant Eli Lilly & Co. (LLY) plummeted 5.03% on Friday, amid a broader market selloff and concerns over the company's legal battles with federal health agencies and the ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LLY","symbol_name":"礼来","start_time":0,"source_url":"","article_id":"1186989778","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186989778","pubTimestamp":1731703976,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of pharmaceutical giant Eli Lilly & Co.  plummeted 5.03% on Friday, amid a broader market selloff and concerns over the company's legal battles with federal health agencies and the potential impact of Robert F. Kennedy Jr.'s nomination as the head of the Department of Health and Human Services .The Indianapolis-based drugmaker's stock took a hit after the company filed a lawsuit against the U.S. Health Resources and Services Administration  over the agency's rejection of Eli Lilly's propo","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LLY":"礼来"},"translate_title":"由于诉讼和小RFK提名令投资者感到恐慌，礼来公司股价暴跌5%","themeId":"8b50228a679c44f870e44bbf889089f6","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1},"content_text":"Shares of pharmaceutical giant Eli Lilly & Co. (LLY) plummeted 5.03% on Friday, amid a broader market selloff and concerns over the company's legal battles with federal health agencies and the potential impact of Robert F. Kennedy Jr.'s nomination as the head of the Department of Health and Human Services (HHS).\nThe Indianapolis-based drugmaker's stock took a hit after the company filed a lawsuit against the U.S. Health Resources and Services Administration (HRSA) over the agency's rejection of Eli Lilly's proposed changes to the way it provides drug discounts to hospitals under the 340B program. The company argued that its new payment model would increase transparency and efficiency, but HRSA deemed it inconsistent with the law.\nAdding to investor concerns, President-elect Donald Trump nominated Robert F. Kennedy Jr., a vocal critic of the pharmaceutical industry and vaccine skeptic, to lead the HHS. Kennedy has expressed opposition to the new class of GLP-1 drugs for weight loss and diabetes management, which are key products for Eli Lilly and its Danish rival Novo Nordisk. Shares of both companies tumbled on the news, as investors feared Kennedy's potential policies could hamper the growth of these lucrative drug franchises.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}